Trial intelligence / Profile preview

INCISIVE: Nurse Practitioner vs Medical Monitoring in Colorectal Cancer

NCT02956876Phase 3Completed

Sponsor
Rouen University Hospital
Start
Dec 2016
Primary completion
Nov 2022
Countries
1
01

Overview

Phase 3, randomised, open-label trial in colorectal cancer (CRC) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Number of side effects of chemotherapy for WHO grade greater than 2 at Day 7. Started Dec 2016; status: completed.

02

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02956876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02956876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call